NCT00864682

Brief Summary

Injection of propofol is associated with discomfort in subsets of patients. Local anesthetics have been shown to attenuate this response in some patients. This randomized, double-blind, placebo-controlled trial tests the hypothesis that lidocaine mixed with propofol will be superior to lidocaine administered directly into the vein, under tourniquet control, prior to injection of propofol. Both groups are expected to be superior to placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for phase_4 pain

Timeline
Completed

Started Jan 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

March 16, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 19, 2009

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
4 months until next milestone

Results Posted

Study results publicly available

August 3, 2009

Completed
Last Updated

January 27, 2021

Status Verified

January 1, 2021

Enrollment Period

1.2 years

First QC Date

March 16, 2009

Results QC Date

March 24, 2009

Last Update Submit

January 8, 2021

Conditions

Keywords

propofollidocaineinjection pain

Outcome Measures

Primary Outcomes (1)

  • Verbal Pain Score

    11 point verbal pain score (VPS) 0=no pain; 10=worst imaginable pain

    Immediately after injection of study drug. One time assessment.

Secondary Outcomes (2)

  • Complete Alleviation of Injection Pain

    Immediately after injection of study drug. One time assessment

  • Satisfaction With Anesthetic Technique

    Prior to discharge. One time assessment

Study Arms (3)

Placebo

PLACEBO COMPARATOR

Saline pretreatment, saline admixture

Drug: Saline

Lidocaine pretreatment

ACTIVE COMPARATOR

Lidocaine pretreatment / saline-propofol admixture

Drug: lidocaine pretreatment

Lidocaine-Propofol admixture

ACTIVE COMPARATOR

saline pretreatment / Lidocaine-propofol admixture

Drug: Lidocaine / propofol admixture

Interventions

SalineDRUG

3.3 mL normal saline

Placebo

lidocaine 50 mg plus propofol 50 mg intravenous (iv)

Lidocaine-Propofol admixture

lidocaine 50 mg iv under tourniquet-control

Lidocaine pretreatment

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • weight \>40kg, \<100kg
  • ambulatory surgery

You may not qualify if:

  • allergy to propofol or lidocaine
  • taking opioids, benzodiazepines, or nonsteroidal antiinflammatory drugs (NSAIDs)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benaroya Research Institute

Seattle, Washington, 98101, United States

Location

Related Publications (1)

  • Walker BJ, Neal JM, Mulroy MF, Humsi JA, Bittner RC, McDonald SB. Lidocaine pretreatment with tourniquet versus lidocaine-propofol admixture for attenuating propofol injection pain: a randomized controlled trial. Reg Anesth Pain Med. 2011 Jan-Feb;36(1):41-5. doi: 10.1097/AAP.0b013e31820306da.

MeSH Terms

Conditions

Pain

Interventions

Sodium ChlorideLidocaine

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsAcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Results Point of Contact

Title
Joseph M. Neal, MD
Organization
Virginia Mason Medical Center

Study Officials

  • Joseph M Neal, MD

    Virginia Mason Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

March 16, 2009

First Posted

March 19, 2009

Study Start

January 1, 2008

Primary Completion

March 1, 2009

Study Completion

April 1, 2009

Last Updated

January 27, 2021

Results First Posted

August 3, 2009

Record last verified: 2021-01

Locations